Plunkett Research Online: COSCIENS Biopharma Inc

COSCIENS BIOPHARMA INC (CSCI:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extra.....



COSCIENS Biopharma Inc
Ticker: CSCI
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 843-900-3211
Fax:
Address: c/o Norton Rose Fulbright Canada LLP
222 Bay Street, Suite 3000
Toronto, ON M5K 1E7 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drug Development
Biopharmaceutical Development
Biopharmaceutical Licensing
Contacts Description
Gilles GagnonCEO/Director/President
Stacy PrefontaineCFO/Secretary
See More
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extra.....See More See More

Auditor: Grant Thornton LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Macimorelin
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: